MOUNTAIN VIEW, California, February 22 /PRNewswire/ --

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that results from the use of its Merci Retrieval System(TM) were featured and discussed in seventeen separate presentations at the International Stroke Conference held in New Orleans, Louisiana, February 20-22, 2008. Positive clinical and economic results from the use of the Merci Retrieval System in patients suffering from acute ischemic stroke were discussed during five main podium presentations and more than 12 poster sessions over the three-day conference, which had more than 3,500 people in attendance.

HELSINKI, February 22 /PRNewswire/ -- Sigmaview Capital Sdn. Bhd. owner of MSC Trustgate, Malaysia's premier provider of Internet trust solutions, and Valimo Wireless, the market leader in Mobile Signature solutions, have signed an agreement concerning a mobile signature pilot in Malaysia.

MSC Trustgate is the qualified licensed CA (Certification Authority) in Malaysia and has started to expand its service offering to other Asian countries, such as Indonesia, Thailand and Vietnam.

STAINES, England, February 22 /PRNewswire/ --

- New Treatment Option Contributes to Fight Against Healthcare Associated Infections

Astellas Pharma Europe Ltd(i) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion by consensus, recommending a marketing authorisation for Mycamine(R), a treatment for systemic fungal infections, which are very serious, life-threatening conditions.

The CHMP's positive recommendation is a critical step in the approval process, and Astellas expects to obtain the European Commission decision in May.

AMSTERDAM, February 22 /PRNewswire/ --

- FDA Approves IND Application for Reviroc(TM)

Biopharmaceutical Company Kiadis Pharma announced today that the US Food and Drug Administration (FDA) approved Kiadis Pharma's investigational new drug ("IND") application to allow the start of a clinical phase III study for its product Reviroc(TM) in the United States. Reviroc(TM) is under development for the elimination of cancer cells from an autologous graft in bone marrow transplantations for end-stage blood cancer patients.

ORLANDO, Florida, February 22 /PRNewswire/ --

- Liberty Alliance Launches Public Special Interest Group to Enable an Internationally Interoperable Healthcare Identity Management and Information Exchange System

LONDON and NEW YORK, February 22 /PRNewswire/ --

LinkShare, a leading pay-per-action marketing network, unveiled today a new publisher dashboard that enables publishers to more easily and effectively manage their affiliate marketing programs. Publishers who participate in LinkShare's global network will have quicker access to programs, links, and commission reports than ever before.